Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
1,559 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
Hoofprint Biome, Inc.Biotechnology
Raleigh, North Carolina · founded 2023 · Simple Agreement for Future Equity · 5 investors · Rodolphe Barrangou, Scott Collins
AOA DX Inc.Biotechnology
Denver, Colorado · founded 2020 · Debt, Options · 15 investors · Alexander Fisher, Surbhi Sarna
AstralBio, Inc.Biotechnology
Boston, Massachusetts · founded 2023 · Equity · 2 investors · Justin DiMartino, Patrick Crutcher
Tharimmune, Inc.Biotechnology
Bridgewater, New Jersey · Equity, Options, Convertible · 7 investors · Thomas Hess, Sireesh Appajosyula
Xcell Biosciences, Inc.Biotechnology
San Francisco, California · Equity · 5 investors · Saeid Akhtari, James Lim
Promedix, Inc.Biotechnology
Portland, Oregon · Options, Convertible · 1 investors · Matthew Hansen, Steven Baker
Gregor Diagnostics, Inc.Biotechnology
Dallas, Texas · Debt, Options, Convertible · 8 investors · Michael Partsch, Lauren Tyra
PEPTINOVO BIOPHARMA INC.Biotechnology
Ann Arbor, Michigan · Equity · 12 investors · David Romenesco, Fred Brown
Collage Bioscience CorpBiotechnology
San Francisco, California · founded 2024 · Simple Agreement for Future Equity (SAFEs) · 2 investors · Neal Amin
ProteoWise Inc.Biotechnology
New Haven, Connecticut · Equity, Options · 6 investors · Daniel Wagner, Benjamin Comb
Transcode Therapeutics, Inc.Biotechnology
Boston, Massachusetts · Equity, Options, Convertible · 6 investors · Magda Marquet, Erik Manting
NeuroSense Therapeutics Ltd.Biotechnology
Herzliya, Israel · Options, Convertible · 2 investors · Cary Claiborne, Mark Leuchtenberger
Resilient Biotics, Inc.Biotechnology
Research Triangle Park, North Carolina · Debt, Options, Convertible · 6 investors · Eric Eason, John Peryam
Scorpius Holdings, Inc.Biotechnology
Morrisville, North Carolina · Debt, Options, Convertible · 2 investors · Edward Smith, John Prendergast
ADIPO THERAPEUTICS, LLCBiotechnology
Indianapolis, Indiana · Equity · 20 investors · Keith Johns, Karen Wurster
Relation Therapeutics Inc.Biotechnology
Lauderhill, Florida · founded 2021 · Debt, Convertible, Convertible Promissory Note · 1 investors · Jim Mellon, David Roblin
OncoVerity, Inc.Biotechnology
Aurora, Colorado · founded 2022 · Equity · 2 investors · Massimiliano Colao, Arjen Lemmen
Pleural Dynamics, Inc.Biotechnology
Wayzata, Minnesota · founded 2020 · Equity, Options, Convertible · 28 investors · Martin Mayse, Mark Deem
GenoPalate, Inc.Biotechnology
Milwaukee, Wisconsin · Equity · 4 investors · John Byrnes, Asif Naseem
Memgen, Inc.Biotechnology
Houston, Texas · Equity · 2 investors · Patricia Bitar, Mark Cantwell
Starling Medical, Inc.Biotechnology
Houston, Texas · founded 2020 · Equity · 40 investors · Shana Barghouti, Kunj Sheth
XiltriX North America, LLCBiotechnology
San Diego, California · Equity · 18 investors · Hendrik Hanselaar, Erik van Stek
Lucid Diagnostics Inc.Biotechnology
New York, New York · Debt · 7 investors · Michael Gordon, Dennis Matheis
HCW Biologics Inc.Biotechnology
Miramar, Florida · Options · 1 investors · Lee Flowers, Gary Winer
XDemics CorpBiotechnology
Novato, California · Equity · 3 investors · Nicole Bergman, Colin Cook
INTENSITY THERAPEUTICS, INC.Biotechnology
Shelton, Connecticut · Options, Convertible · 1 investors · Thomas Dubin, Mark Goldberg
Manifold Biotechnologies, Inc.Biotechnology
Boston, Massachusetts · Equity, Options, Convertible · 10 investors · Jory Bell, Gleb Kuznetsov
Gemelli Biotech Corp.Biotechnology
Raleigh, North Carolina · Equity · 128 investors · John Neczesny, Matthew Mitcho
Ambient Biosciences, Inc.Biotechnology
Ann Arbor, Michigan · Equity, Options, Convertible · 9 investors · Paul Meister, Matthew Cobbett
Exxel Pharma, INC.Biotechnology
Aurora, Colorado · Debt · 1 investors · Soren Mogelsvang, Guy Yachin